SCHEMBL22901620

SCHEMBL22901620

COc1cccc(COc2cccc3ccc(-c4ccncn4)nc23)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 6/20 0.48
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP3A4 P08684 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HTR1A P08908 4/20 0.46
DRD2 P14416 3/20 0.46
SGMS2 Q8NHU3 1/20 0.45
PIM1 P11309 2/20 0.43
PIM2 Q9P1W9 2/20 0.43
PDE10A Q9Y233 2/20 0.43
PRKACA P17612 1/20 0.43
ROCK1 Q13464 1/20 0.43
GCK P35557 1/20 0.42
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22901618 0.87 MAPT (0.52) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901619 0.85 MAPT (0.50) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901623 0.84 MAPT (0.49) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901567 0.84 MAPT (0.51) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901622 0.83 MAPT (0.50) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901624 0.83 MAPT (0.47) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901562 0.81 MAPT (0.50) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901583 0.80 MAPT (0.52) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901547 0.80 MEN1 (0.51) ABCB1MAPTHTTSMN1; SMN2MEN1
SCHEMBL22901554 0.79 MAPT (0.51) ABCB1MAPTHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021008588-A1 CLASS OF PYRIMIDINE QUINOLINE DERIVATIVES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广州新民培林医药科技有限公司 2021-01-21 WO disclosed